A detailed history of Novare Capital Management LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Novare Capital Management LLC holds 170,119 shares of MRK stock, worth $21.1 Million. This represents 2.05% of its overall portfolio holdings.

Number of Shares
170,119
Previous 162,463 4.71%
Holding current value
$21.1 Million
Previous $17.7 Million 26.74%
% of portfolio
2.05%
Previous 1.8%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 06, 2024

BUY
$113.24 - $131.95 $866,965 - $1.01 Million
7,656 Added 4.71%
170,119 $22.4 Million
Q4 2023

Feb 08, 2024

BUY
$100.18 - $109.02 $762,169 - $829,424
7,608 Added 4.91%
162,463 $17.7 Million
Q3 2023

Nov 02, 2023

BUY
$102.95 - $114.33 $613,582 - $681,406
5,960 Added 4.0%
154,855 $15.9 Million
Q2 2023

Jul 28, 2023

SELL
$108.61 - $118.38 $119,688 - $130,454
-1,102 Reduced 0.73%
148,895 $17.2 Million
Q1 2023

Apr 20, 2023

SELL
$102.94 - $114.86 $1.94 Million - $2.17 Million
-18,884 Reduced 11.18%
149,997 $16 Million
Q4 2022

Jan 17, 2023

SELL
$87.44 - $112.11 $470,864 - $603,712
-5,385 Reduced 3.09%
168,881 $0
Q3 2022

Oct 11, 2022

BUY
$84.53 - $94.96 $1.06 Million - $1.19 Million
12,517 Added 7.74%
174,266 $15 Million
Q2 2022

Aug 03, 2022

BUY
$83.49 - $94.64 $4.6 Million - $5.22 Million
55,123 Added 51.7%
161,749 $14.7 Million
Q1 2022

May 09, 2022

BUY
$73.51 - $82.4 $326,972 - $366,515
4,448 Added 4.35%
106,626 $8.75 Million
Q4 2021

Feb 03, 2022

BUY
$72.28 - $90.54 $209,828 - $262,837
2,903 Added 2.92%
102,178 $7.83 Million
Q3 2021

Nov 04, 2021

BUY
$71.68 - $78.83 $389,222 - $428,046
5,430 Added 5.79%
99,275 $7.46 Million
Q2 2021

Aug 02, 2021

BUY
$70.31 - $77.77 $6.29 Million - $6.96 Million
89,502 Added 2060.83%
93,845 $7.3 Million
Q1 2021

May 11, 2021

SELL
$68.86 - $81.11 $187,643 - $221,024
-2,725 Reduced 38.55%
4,343 $335,000
Q1 2021

May 07, 2021

BUY
$68.86 - $81.11 $167,260 - $197,016
2,429 Added 52.36%
7,068 $575,000
Q4 2020

Feb 01, 2021

SELL
$71.77 - $79.65 $6,818 - $7,566
-95 Reduced 2.01%
4,639 $379,000
Q3 2020

Nov 03, 2020

BUY
$73.18 - $82.95 $24,295 - $27,539
332 Added 7.54%
4,734 $393,000
Q2 2020

Aug 06, 2020

SELL
$70.42 - $80.13 $82,461 - $93,832
-1,171 Reduced 21.01%
4,402 $340,000
Q1 2020

May 05, 2020

BUY
$63.36 - $87.82 $74,764 - $103,627
1,180 Added 26.86%
5,573 $429,000
Q4 2019

Feb 06, 2020

BUY
$77.58 - $87.54 $80,915 - $91,304
1,043 Added 31.13%
4,393 $400,000
Q3 2019

Nov 12, 2019

BUY
$76.08 - $82.93 $3,499 - $3,814
46 Added 1.39%
3,350 $269,000
Q1 2019

May 09, 2019

SELL
$69.58 - $79.36 $4,174 - $4,761
-60 Reduced 1.78%
3,304 $275,000
Q4 2018

Feb 12, 2019

BUY
$65.24 - $75.71 $65 - $75
1 Added 0.03%
3,364 $257,000
Q3 2018

Nov 09, 2018

SELL
$57.69 - $67.84 $5,826 - $6,851
-101 Reduced 2.92%
3,363 $239,000
Q2 2018

Aug 10, 2018

SELL
$50.83 - $59.72 $130,226 - $153,002
-2,562 Reduced 42.52%
3,464 $210,000
Q1 2018

May 09, 2018

SELL
$50.96 - $59.23 $3,312 - $3,849
-65 Reduced 1.07%
6,026 $328,000
Q4 2017

Feb 06, 2018

BUY
$51.62 - $61.64 $6,710 - $8,013
130 Added 2.18%
6,091 $343,000
Q3 2017

Nov 07, 2017

BUY
$58.67 - $63.13 $349,731 - $376,317
5,961
5,961 $382,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $314B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Novare Capital Management LLC Portfolio

Follow Novare Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Novare Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Novare Capital Management LLC with notifications on news.